Search

Your search keyword '"Buti S"' showing total 3 results
Start Over Author "Buti S" Language italian
3 results on '"Buti S"'

1. Basi scientifiche per la definizione di linee-guida in ambito clinico per il Carcinoma Renale

Author

Boccardo F, Silvestrini R, Battaglia M, Bollito E, Bracarda S, Carini M, Carmignani G, Conti G, Corvò R, Ficarra V, Gatta G, Montorsi F, Passalacqua R, Pavlica P, Porta C, Puppo P, Salvioni R, Barozzi L. Brunelli M, Buti S, Caminiti C, Cestari A, Guazzoni G, Martignoni G, Oneto F, Ricci F, Rigatti P, Righi L, Riva M, Sangalli M, Scapaticci E, Stagni S, Tomasello L, Valentino M., MARTORANA, GIUSEPPE, FRANCESCHELLI, ALESSANDRO, SANGUEDOLCE, FRANCESCO, SCHIAVINA, RICCARDO, Boccardo F, Silvestrini R, Battaglia M, Bollito E, Bracarda S, Carini M, Carmignani G, Conti G, Corvò R, Ficarra V, Gatta G, Martorana G, Montorsi F, Passalacqua R, Pavlica P, Porta C, Puppo P, Salvioni R, Barozzi L Brunelli M, Buti S, Caminiti C, Cestari A, Franceschelli A, Guazzoni G, Martignoni G, Oneto F, Ricci F, Rigatti P, Righi L, Riva M, Sangalli M, Sanguedolce F, Scapaticci E, Schiavina R, Stagni S, Tomasello L, and Valentino M

Subjects
Basi scientifiche per la definizione di linee-guida in ambito clinico per il Carcinoma Renale, urologic and male genital diseases
Abstract

Basi scientifiche per la creazione delle linee guida per la diagnosi e il tratamento del tumore renale

Published
2008

3. [Influenza vaccination in advanced cancer patients undergoing immunotherapy with anti-PD-1/PD-L1 immune checkpoint inhibitors: what data do we have for the clinical recommendation?]

Author

Bersanelli M, Buti S, De Giorgi U, Di Maio M, Giannarelli D, and Banna GL

Subjects
B7-H1 Antigen antagonists & inhibitors, B7-H1 Antigen immunology, Humans, Immunotherapy methods, Influenza Vaccines adverse effects, Influenza Vaccines immunology, Influenza, Human immunology, Neoplasms immunology, Programmed Cell Death 1 Receptor antagonists & inhibitors, Programmed Cell Death 1 Receptor immunology, Influenza Vaccines administration & dosage, Influenza, Human prevention & control, Neoplasms therapy
Abstract

Influenza vaccination is recommended by national and international guidelines in cancer patients, due to the likely compromised immune status and the risk of major complications from the infection. Nevertheless, the infectious morbidity and mortality of cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors have not been explored. Currently, no solid data support the efficacy and safety of influenza vaccination in this subgroup. The few available retrospective studies suggest a low efficacy of the vaccine, posing legitimate doubts about its safety. On the other hand, influenza vaccination does not seem to compromise the efficacy of immunotherapy. In conclusion, current data are limited and do not allow a unique recommendation about influenza vaccination during cancer immunotherapy, suggesting a conservative attitude and a personalized assessment of risks and benefits pending prospective data.

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results